Radiotherapy Market Worth 7,544.8 Million USD by 2020

The report "Radiotherapy Market by Technology (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer)) - Global Forecasts to 2020", The radiotherapy market is expected to reach USD 7,544.8 Million by 2020 from USD 5,585.0 Million in 2015, at a CAGR of 6.2% between 2015 and 2020.


Pune, India -- (SBWIRE) -- 02/02/2016 -- Browse 91 market tables and 48 figures spread through 177 pages and in-depth TOC on "Radiotherapy Market"

Early buyers will receive 10% customization on report.

Technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures will majorly drive the radiotherapy market.

This report broadly segments the global radiotherapy market into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. In 2015, the external beam radiotherapy segment is expected to account for the largest share of the global radiotherapy market. By product, the external beam radiotherapy is further classified into compact advanced radiotherapy devices (Cyberknife, Gammaknife, and Tomotherapy), proton therapy systems (cyclotrons and synchrotrons), and electron emitting high energy linear accelerators. The internal radiotherapy market, by product is further segmented into seeds, applicators & afterloaders, and electronic brachytherapy.

Ask For The PDF Brochure:

On the basis of technology, the global radiotherapy market is segmented into external beam radiotherapy (intensity-modulated radiation therapy, image-guided radiotherapy, tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy), internal beam radiotherapy (high dose rate and low dose rate), and systemic radiation therapy. In 2015, the image-guided radiotherapy technology is expected to account for the largest share of the global radiotherapy market, by technology.

Based on application, the external beam radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and others (spine cancer and brain cancer). The internal radiotherapy, by applications is further divided into prostate cancer, gynaecological cancer, breast cancer, cervical cancer, penile cancer, and others (lung cancer and head & neck cancer). In 2015, the prostate cancer application segment is expected to account for the largest share in both external beam radiotherapy market as well as internal radiotherapy market, by application.

This report covers the radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to hold the largest share of this market in 2015, while Asia-Pacific is expected to grow at the fastest rate during the forecast period from 2015 to 2020. Increasing number of cancer patients in Asia-Pacific region is expected to drive the radiotherapy market in this region.

Get The Sample Copy Of This Report:

Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Nordion, Inc. (Canada), RaySearch Laboratories AB (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the global radiotherapy market.

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India
Tel: 888-6006-441
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @